Skip to main content
ANAGENICS LIMITED logo

ANAGENICS LIMITED — Investor Relations & Filings

Ticker · AN1 ISIN · AU0000198095 ASX Manufacturing
Open in API
Filings indexed 1,067 across all filing types
Latest filing 2019-07-03 Earnings Release
Country AU Australia
Listing ASX AN1

About ANAGENICS LIMITED

https://anagenics.com

Anagenics Limited is a health and wellness company focused on the development and commercialization of science-based anti-aging and longevity solutions. The company specializes in the research and distribution of clinically validated products targeting hair loss and skin health. Its core portfolio includes the évolis brand, which utilizes proprietary FGF5 inhibitor technology to promote hair growth and improve hair health. Through its subsidiaries, such as Advangen and BLC Cosmetics, the company manages a diverse range of premium skincare and wellness brands. Anagenics operates across international markets, providing consumer-facing products and professional-grade treatments backed by scientific research. The company's strategic focus remains on expanding its presence in the global beauty-tech and wellness sectors by leveraging its intellectual property and distribution networks.

Recent filings

Filing Released Lang Actions
Cellmid Sets Another Sales Record in Q4 FY2019 2 pages 89.5KB
Earnings Release Classification · 95% confidence The document is an ASX announcement from Cellmid Limited reporting record sales figures for Q4 FY2019. It provides sales revenue data and commentary from the CEO about operational momentum and sales growth. The document is relatively short (3914 characters) and focuses on sales performance highlights rather than detailed financial statements or comprehensive financial analysis. There is no indication that this is a full quarterly or annual report, nor is it a transcript, audit report, or other regulatory filing. It is an earnings-related announcement but does not contain full financial results or detailed financial statements, so it fits best as an Earnings Release (ER). Q4 2019
2019-07-03 English
Change of Director's Interest Notice - Halasz 2 pages 547.6KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rules and the Corporations Act. It details changes in securities holdings by a company director, including the number of shares held before and after the change, the nature of the change (on-market purchase), and other related information. This matches the description of a Director's Dealing report, which reports personal share transactions by company directors and executives (insider trades). The document is not an announcement of a report, nor does it contain financial statements or management commentary. Therefore, the correct classification is Director's Dealing (DIRS).
2019-06-06 English
Cellmid appoints new Lyramid CEO 2 pages 207.5KB
Board/Management Information Classification · 100% confidence The document is an ASX announcement about the appointment of a new CEO for a subsidiary company, Lyramid, within Cellmid Limited. It details the individual's background, the strategic rationale for the appointment, and the terms of his remuneration package. There is no financial data, no mention of a report or filing, no voting results, no legal proceedings, no capital changes, and no earnings information. The content is focused on management changes at a senior level. Therefore, the document fits the category of Board/Management Information (MANG). The document length is 4175 characters, which is consistent with a typical announcement rather than a full report or transcript.
2019-05-27 English
FY2020 Growth Strategy Update 16 pages 1.5MB
Investor Presentation Classification · 95% confidence The document is a detailed presentation titled 'FY2020 Growth Strategy Update' dated May 2019. It includes forward-looking statements, operational updates, strategic objectives, leadership team bios, market expansion plans, and product development information. The content is focused on business strategy, market positioning, sales growth, and management team details rather than financial statements or regulatory filings. It is structured as a presentation with slides and images (not included here) and is intended for investors or stakeholders to understand the company's growth strategy and outlook. There is no indication that this is an official annual or quarterly report, audit report, earnings release, or regulatory filing. The document fits the description of an Investor Presentation, which is a detailed presentation for investors focusing on financials, strategy, and market position.
2019-05-27 English
Minimum Holding Buy-Back Complete - ASIC Form 484 3 pages 286.1KB
Transaction in Own Shares Classification · 100% confidence The document is an ASX announcement titled 'MINIMUM HOLDING BUY-BACK COMPLETED' indicating the completion of a share buy-back program. It includes details of shares bought back, cancellation of shares, and an ASIC Form 484 filing related to the cancellation. The document is relatively short (4829 characters) and primarily serves as an announcement of the buy-back completion and related regulatory filing. It does not contain comprehensive financial statements or detailed financial analysis. Therefore, it is not a full financial report but an announcement of a capital change event. According to the filing definitions, announcements regarding share buy-backs or capital changes fall under 'Transaction in Own Shares (POS)'.
2019-05-22 English
Minimum Holding Buy-Back Closed 1 page 276.2KB
Transaction in Own Shares Classification · 95% confidence The document is an ASX announcement titled 'MINIMUM HOLDING BUY-BACK CLOSED' dated 21 May 2019. It details the completion of a share buy-back program, specifying the number of shares bought back, the price, total consideration, and the purpose of the buy-back. There are no financial statements or detailed financial analysis present, and the document is relatively short (3253 characters). It is clearly an announcement about a share repurchase transaction rather than a full financial report or earnings release. Therefore, it fits the category of 'Transaction in Own Shares' (POS).
2019-05-20 English

Browse filings by year

22 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.